发明名称 TCL1 EXPRESSION REGULATED BY MIR-29 AND MIR-181 IN CHRONIC LYMPHOCYTIC LEUKEMIA
摘要 PROBLEM TO BE SOLVED: To provide novel methods and compositions for the diagnosis, prognosis and treatment of chronic lymphocytic leukemia (CLL).SOLUTION: This invention provides a method for diagnosing whether a subject is suffering from, or is at risk for developing chronic lymphocytic leukemia (B-CLL), the method comprising measuring the level of at least one miR gene product in a test sample from the subject. In the method, an alteration in the level of the miR gene product in the test sample relative to the level of a corresponding miR gene product in a control sample indicates that the subject is suffering from, or is at risk for developing B-CLL.
申请公布号 JP2014113146(A) 申请公布日期 2014.06.26
申请号 JP20130245015 申请日期 2013.11.27
申请人 OHIO STATE UNIV RESEARCH FOUNDATION:THE 发明人 CROCE CARLO M
分类号 C12Q1/68;A61K31/7105;A61K48/00;A61P35/02;C12N15/09;G01N33/53;G01N33/574;G01N37/00 主分类号 C12Q1/68
代理机构 代理人
主权项
地址